Oncology & Cancer

Patients with rare skin cancer face 40% recurrence rate

Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40%—markedly higher than the recurrence rates for melanoma and other skin cancers, according to research published today in JAMA Dermatology.

Oncology & Cancer

Skin cancer app fails to identify rare, aggressive cancers

(HealthDay)—A direct-to-consumer machine learning model for detecting skin cancers may not adequately recognize rare, but aggressive, skin cancers, according to a study presented at the annual meeting of the European Academy ...

Medical research

Scientists identify principal protein sensor for touch

A team led by biologists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in neuroscience by identifying the "mechanoreceptor" protein that mediates the sense of touch in mammals.

Neuroscience

How a light touch can spur severe itching

For some people, particularly those who are elderly, even a light touch of the skin or contact with clothing can lead to unbearable itching. What's worse, anti-itch treatments, including hydrocortisone, don't provide much ...

Oncology & Cancer

Cancer researchers find key oncoprotein in Merkel cell carcinoma

Researchers at the University of Pittsburgh Cancer Institute (UPCI) have identified the oncoprotein that allows a common and usually harmless virus to transform healthy cells into a rare but deadly skin cancer called Merkel ...

page 1 from 5